Novel immunotherapeutic strategies for colorectal cancer treatment: Advances, challenges, and future directions
{{output}}
Immunotherapy has reshaped the treatment landscape of colorectal cancer (CRC), with the clearest and most durable benefit established in mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) disease. However, framing CRC immunotherapy simply... ...